Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 515,595
  • Shares Outstanding, K 29,547
  • Annual Sales, $ 312,690 K
  • Annual Income, $ -274,880 K
  • 60-Month Beta 1.42
  • Price/Sales 1.57
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ICPT with:

Options Overview Details

View History
  • Implied Volatility 153.28% ( -14.67%)
  • Historical Volatility 73.45%
  • IV Percentile 94%
  • IV Rank 71.46%
  • IV High 185.89% on 11/10/21
  • IV Low 71.62% on 07/20/21
  • Put/Call Vol Ratio 0.35
  • Today's Volume 1,801
  • Volume Avg (30-Day) 1,977
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 36,181
  • Open Int (30-Day) 24,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -1.25
  • Number of Estimates 8
  • High Estimate -0.48
  • Low Estimate -2.32
  • Prior Year -1.58
  • Growth Rate Est. (year over year) +20.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.45 +17.65%
on 01/10/22
18.28 -7.00%
on 12/23/21
+0.33 (+1.98%)
since 12/20/21
3-Month
13.51 +25.83%
on 12/15/21
20.50 -17.07%
on 11/03/21
-0.21 (-1.22%)
since 10/20/21
52-Week
11.60 +46.55%
on 08/20/21
38.94 -56.34%
on 01/27/21
-11.45 (-40.25%)
since 01/20/21

Most Recent Stories

More News
3 Can't-Miss Biotech Events Coming Up in 2022

This could be a very exciting year for these drugmakers.

ALNY : 138.31 (-0.22%)
ICPT : 17.00 (-2.58%)
KRTX : 111.75 (-0.83%)
Intellia (NTLA) Inks Deal With Kyverna for Autoimmune Diseases

Intellia (NTLA) inks a licensing and collaboration deal with Kyverna Therapeutics for developing an allogeneic CAR T-cell therapy for autoimmune diseases.

REGN : 614.38 (-0.60%)
ICPT : 17.00 (-2.58%)
VTVT : 0.8599 (+3.27%)
NTLA : 82.62 (-1.25%)
Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASH

Study remains ongoing; top-line data anticipated in Q1 2022 versus near the end of the year...

ICPT : 17.00 (-2.58%)
Intercept (ICPT) Down on Withdrawal of Application for NASH

Intercept (ICPT) withdraws its application seeking approval for OCA for the treatment of liver fibrosis due to nonalcoholic steatohepatitis in the EU. Resultantly, the stock declines.

SRPT : 64.59 (+2.28%)
ICPT : 17.00 (-2.58%)
VKTX : 3.95 (-1.74%)
VTVT : 0.8599 (+3.27%)
Is the Options Market Predicting a Spike in Intercept (ICPT) Stock?

Investors need to pay close attention to Intercept (ICPT) stock based on the movements in the options market lately.

ICPT : 17.00 (-2.58%)
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH

NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), a biopharmaceutical company focused on the development and...

ICPT : 17.00 (-2.58%)
Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%

Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...

HOTH : 0.7153 (-2.03%)
SAVA : 37.41 (-9.13%)
CEI : 0.6096 (-6.93%)
BIIB : 225.91 (-2.12%)
ICPT : 17.00 (-2.58%)
Noteworthy Monday Option Activity: ICPT, SWBI, PINS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Intercept Pharmaceuticals Inc , where a total volume of 10,380 contracts has been traded...

ICPT : 17.00 (-2.58%)
Intercept Announces New Long-Term Data Demonstrating Potential of Obeticholic Acid to Improve Transplant-Free Survival in Patients with PBC

Analysis compares findings from the long-term safety extension of the Phase 3 POISE trial to PBC natural history data from the Global PBC and UK-PBC...

ICPT : 17.00 (-2.58%)
Intercept to Present at Upcoming Investor Conferences

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...

ICPT : 17.00 (-2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR)....

See More

Key Turning Points

3rd Resistance Point 19.02
2nd Resistance Point 18.60
1st Resistance Point 17.80
Last Price 17.00
1st Support Level 16.57
2nd Support Level 16.15
3rd Support Level 15.35

See More

52-Week High 38.94
Fibonacci 61.8% 28.50
Fibonacci 50% 25.27
Fibonacci 38.2% 22.04
Last Price 17.00
52-Week Low 11.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar